In regard to the targeting of GSH biosynthesis via proteolytic degradation of GCLC (Section 3.1.3), the rate limiting enzyme for GSH biosynthesis, it must be noted that there have been a number of reports implicating GSH deficits as a major factor in COVID-19 severity and pathogenesis. Here, GCLC is linked to COVID-19.